Great news for TScan Therapeutics, Inc. (NASDAQ:TCRX): Insiders acquired stock in large numbers last year

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in TScan Therapeutics, Inc.’s (NASDAQ:TCRX) instance, it’s good news for shareholders.
While insider transactions are not the most…

Click here to view the original article.